| Sandra Korszoloski, LPN | |
|
2250 Wehrle Dr, Suite 1, Williamsville, NY 14221-7037 | |
| (716) 276-2123 | |
| (716) 276-2129 |
| Full Name | Sandra Korszoloski |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 2250 Wehrle Dr, Williamsville, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023251071 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 263775 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sandra Korszoloski, LPN 112 Vermont Ave, Lockport, NY 14094-5732 Ph: (716) 433-3130 | Sandra Korszoloski, LPN 2250 Wehrle Dr, Suite 1, Williamsville, NY 14221-7037 Ph: (716) 276-2123 |
News Archive
As the nation moves to significantly reduce trans fat consumption, the American Heart Association is launching "Face The Fats," an educational campaign to teach consumers how to minimize trans fat in their diet, while avoiding the unintended health consequence of defaulting to more saturated fat.
Participation in activities that promote mental activity, and moderate physical activity in middle age, may help protect against the development of Alzheimer's disease and dementia in later life, according to new research reported today at the Alzheimer's Association International Conference- 2014 (AAIC- 2014) in Copenhagen.
The health IT landscape has changed fundamentally in the first year since the American Recovery and Reinvestment Act was signed into law. American patients are seeing their doctors make the switch to Electronic Health Record (EHR) systems, according to a survey conducted by GfK Roper for Practice Fusion, the fastest growing EHR community in the US.
MolecularMD Corp announced today that it has moved their core operations to a expanded dedicated facility with capacity and functionality to support the expansion of its cancer molecular diagnostics business.
Novartis announced today the results of a pivotal Phase II trial demonstrating that patients with locally advanced (laBCC) or metastatic basal cell carcinoma (mBCC) taking the investigational oral compound LDE225 (sonidegib) had marked and sustained tumor shrinkage after a median follow-up of 13.9 months.
› Verified 6 days ago
Ebow Hanson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2250 Wehrle Dr, Suite 1, Williamsville, NY 14221 Phone: 716-276-2123 Fax: 716-276-2129 | |
Justin Washington, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2250 Wehrle Dr, Suite 1, Williamsville, NY 14221 Phone: 716-276-2123 Fax: 716-276-2129 | |
Nichole Minter, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2250 Wehrle Dr, Suite 1, Williamsville, NY 14221 Phone: 716-276-2123 Fax: 716-276-2129 | |
Kasey Turrell, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2250 Wehrle Dr, Suite 1, Williamsville, NY 14221 Phone: 716-276-2123 Fax: 716-276-2129 | |
Jennifer Stanford, L.P.N. Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2250 Wehrle Dr, Suite 1, Williamsville, NY 14221 Phone: 716-276-2123 Fax: 716-276-2129 | |
Heather A Sargent, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2250 Wehrle Dr, Williamsville, NY 14221 Phone: 716-276-2123 | |
Alexa Mercado, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2250 Wehrle Dr Ste 1, Williamsville, NY 14221 Phone: 716-276-2123 |